Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Pre-Interphex 2010 Product Releases.

Pharmaceutical Technology
Volume 34, Issue 3, pp. 83-87



Weldable tubing
PureWeld weldable thermoplastic elastomer (TPE) tubing is suitable for biopharmaceutical processes from research to production. The product is designed to produce a quick, secure, and connector-free fluid path. The TPE contains no animal-derived material that could leach into products. Each piece of tubing displays its lot number and expiration date. Watson-Marlow, Wilmington, MA http://www.watson-marlow.com/ tel. 800.282.8823



Single-use solutions
The FlexAct system focuses on biomanufacturing unit operations and can be used with preconfigured single-use equipment for upstream and downstream processing steps. The system allows users of stainless-steel equipment or individual disposable components to convert to single-use unit operations. Sartorius Stedim Biotech, Bohemia, NY http://www.sartorius-stedim.com/ tel. 800.368.7178



Syringe-closing unit
A rotating, 16-head closing unit receives filled syringe bodies and pistons simultaneously. Because air must be vented during the closing process, each syringe is compressed into oval shape briefly, while air is vented at the piston seal. The process does not affect material or syringe properties, and it implements air evacuation under continuous operation. Optima Group Pharma, Green Bay, WI http://www.optima-usa.com/ tel. 920.339.2222



Gravimetric feeder
The PureFeed DP-4 gravimetric feeder accurately meters dry powders at feed rates as low as 20 g/h. A speed-controlled, inert, ceramic feed disc positioned at the base of a cylindrical, electropolished, stainless-steel material-storage chamber allows the feeder to discharge dry powders precisely, continuously, and without pulsation in a 20–2000-g feed-rate range. Schenck AccuRate, Whitewater, WI http://www.accuratefeeders.com/ tel. 888.742.1249


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here